Pay in 4 interest-free payments of $6.81 Learn more
Ships within 48 hours · Estimated delivery Oct 5 - Oct 10
A total of 343 patients with T1D (A1C above 7% and below 10%, on once-daily basal insulin and rapid-acting insulin analogs for at least one year) were randomized (1:1) to receive either insulin glargine U-300 (172 patients) or insulin degludec U-100 (171 patients)
With PlexusDx, your treatment plan can be informed by your genetic predispositions from the first injection, potentially accelerating results and reducing side effects through earlier optimization
Euglycaemic ketoacidosis in patients with and without diabetes
Research tool Calculate the volume that corresponds to a specified amount of peptide for research purposes, based on vial, solvent and syringe scale
US$ 26.81
US$ 22.88
US$ 26.92
US$ 21.58
US$ 22.53
US$ 20.39
